Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Condition(s):Dry Eye Syndromes; Keratoconjunctivitis SiccaLast Updated:January 6, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Dry Eye Syndromes; Keratoconjunctivitis SiccaLast Updated:January 6, 2021Completed
Condition(s):Dry Eye Disease; Keratoconjunctivitis SiccaLast Updated:July 21, 2011Completed
Condition(s):Conjunctivitis, VernalLast Updated:December 14, 2021Completed
Condition(s):Dry Eye Syndromes; Sjogren Syndrome With KeratoconjunctivitisLast Updated:October 28, 2022Completed
Condition(s):Chronic Graft-versus-host DiseaseLast Updated:October 10, 2016Completed
Condition(s):Dry Eye; Dry Eye Syndromes; Keratoconjunctivitis SiccaLast Updated:October 19, 2021Completed
Condition(s):Ocular Rosacea; Keratoconjunctivitis; Meibomian Gland DysfunctionLast Updated:May 13, 2020Completed
Condition(s):Dry Eye SyndromesLast Updated:May 16, 2023Recruiting
Condition(s):Dry EyeLast Updated:January 8, 2015Completed
Condition(s):Healthy Subjects; Moderate to Severe Keratoconjunctivitis Sicca (KCS); Dry Eye Syndrome (DES)Last Updated:April 23, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.